Image

Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis

Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis

Non Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

This prospective kohort study will follow 150 patients treated with proximal medial gastrocnemius recession for plantar fasciitts. Follow up time is two years and the main outcome is the Manchester Oxford Foot Questionnaire.

A regression analasys will be performed to identify possible patient baseline factors that may affect the effect of surgery,

Description

Recent studies indicate that chronic plantar fasciitis can be treated effectively with Proximal Medial Gastrocnemius Recession (PMGR). In our hospital this treatment has been inocorporated into routine care. This prospective kohort study will follow 150 patients with chronic planatar fasciitis operated with PMGR study. The follow up time is 2 years and the study aims at documenting the effect of the surgery with PROMS (patient related outcome measures), MRI (magnetic resonnance imaging) and ankle movement measurements. 26 patient-related baseline factors will also be registered. A regression analysis will be performed to identify factors that may be predictive to the effect of PMGR surgery.

Eligibility

Inclusion criteria:

  1. Age 18-75 years.
  2. Diagnosis plantar fasciitis verified clinically by orthopaedic surgeon.
  3. Diagnosis verified by MRI. MRI criteria: Thickening of the plantar fascia, oedema in the calcaneus, pathological singal changes in the plantar fascia (37)
  4. Duration of symptoms must be at least 12 months.
  5. An isolated gastrocnemius contracture must be verified with the Silverskiölds test before inclusion.
  6. Conventional Physical Therapy must have been tried at least three months without positive effects on symptoms from affected foot.

Exclusion criteria:

  1. Previously undergone surgery for plantar fasciitis.
  2. Patients with severe talocrural pathology or serious malalignment of foot and ankle
  3. Severely reduced peripheral circulation or chronic ulcerations of the foot
  4. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
  5. Patients with a contraindication/non-compliance for MRI examination.
  6. Unable to walk without aid.
  7. Not able to read and/or speak a Scandinavian language or English adequately.

Study details
    Chronic Plantar Fasciitis

NCT05162144

Ostfold Hospital Trust

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.